Skip to content

Clinical trials

Observational Fallopian Tube Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Observational Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20053
20064
20073
20081
20093
20105
20118
20121
20141
20154
20165
20175
20183
20194
20208
20214
20222
20231
20246
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Unknown status11
Recruiting10
Terminated9
Active, not recruiting4
Not yet recruiting3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group9
AstraZeneca4
M.D. Anderson Cancer Center4
Memorial Sloan Kettering Cancer Center4
Royal Marsden NHS Foundation Trust4
National Cancer Institute (NCI)3
Precision Therapeutics3
Duke University2
Grupo Español de Investigación en Cáncer de Ovario2
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms81
Ovarian Neoplasms68
Carcinoma, Ovarian Epithelial20
Uterine Cervical Neoplasms18
Endometrial Neoplasms17
Vulvar Neoplasms13
Vaginal Neoplasms10
Breast Neoplasms9
Esophageal Neoplasms8
Neoplasms8

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.